Mylan Launches First Duragesic Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
ANDA approval comes five days after J&J's pediatric exclusivity on the fentanyl patch expired. Mylan's product will face competition from Sandoz' "authorized" generic.